On translation of antibody drug conjugates efficacy from mouse experimental tumors to the clinic: a PK/PD approach

Author： Haddish-Berhane Nahor   Shah Dhaval   Ma Dangshe   Leal Mauricio   Gerber Hans-Peter   Sapra Puja   Barton Hugh   Betts Alison  

Publisher： Springer Publishing Company

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.40, Iss.5, 2013-10, pp. : 557-571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigational antibody drug conjugates for solid tumors

By Sapra Puja   Hooper Andrea T   O'Donnell Christopher J   Gerber Hans-Peter  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1131-1149

Informa Healthcare

Access to resources Recommend Favorite

A Bayesian Approach for PK/PD Modeling with PD Data Below Limit of Quantification

By Zhou Huafeng  

Journal of Biopharmaceutical Statistics, Vol. 22, Iss. 6, 2012-11 ,pp. : 1220-1243

Taylor & Francis Ltd

Access to resources Recommend Favorite

Editorial: Efficacy, Toxicology, and PK/PD of Nanomedicine Administrated by Different Strategies

By  

Current Drug Metabolism, Vol. 19, Iss. 2, 2018-04 ,pp. : 84-84

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal antibody–drug conjugates

By Hamann Philip R  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 9, 2005-09 ,pp. : 1087-1103

Informa Healthcare

Access to resources Recommend Favorite

Translational PK-PD modeling in pain

By Yassen Ashraf  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 3, 2013-06 ,pp. : 401-418

Springer Publishing Company

Access to resources Recommend Favorite